DCC-2036

· Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCC-2036, covering 2014-07-18 to 2014-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation) [Phase 1]

See pricing